FAS and malignant colon neoplasm: Since many FAS inhibitors are reported to have the ability of treating human colon cancer, our results suggest that R. apiculata and LR can be considered to have the application potential in treatment of human colon cancer, and they may offer some ideas and clues for developing target-directed anticancer drugs for further in vivo studies.